First Blood Test for Concussion Gets FDA Approval in United States

Table of Contents

A US company has been given approval to develop a commercial blood test that can identify certain indicators of visible brain trauma following a mild traumatic brain injury (TBI) or concussion. This is seen by some as the first step in developing an accurate blood test that can detect concussion and other brain injuries.

Marketing approval granted for a device that assists in testing for concussion

This February, the FDA granted permission for Banyan Biomarkers to develop and market a commercial blood test that evaluates mild traumatic brain injury, or concussion.

Currently, suspected concussions are assessed using a 15-point \”Glasgow Coma Score\” scale. Patients with symptoms will then be given a CT scan to identify any bleeding, intracranial lesions or trauma that may require further treatment. However, in most cases of mild TBI, these scans reveal no visible brain damage whatsoever.

The Banyan Brain Trauma Indicator (BTI) can measure the levels of two \”biomarkers\” that are released in to the blood within twelve hours of a brain injury. These biomarkers occur in cases of concussion where patients have suffered visible damage to their brains. In testing, the BTI predicted the presence of visible brain trauma in 97.5% of patients. Where no biomarkers were found by the BTI, 99.6% of the individuals tested had no visible damage.

New technologies can improve diagnosis and treatment for traumatic brain injury

By using an inexpensive and easily administered blood test to detect the presence of visible brain damage, the Banyan BTI will help doctors prioritize cases with intracranial trauma, while avoiding unnecessary CT scans in patients lacking the necessary biomarkers. This not only prevents unnecessary exposure to radiation, but also saves money for the health care system and reduces the demand for limited equipment.

This new device may be also be the first step in development of a technology that can accurately determine whether an individual has suffered a mild TBI or concussion within a short time frame.

Toronto Personal Injury Lawyers for Traumatic Brain Injury and Concussion

At Jasmine Daya & Co., we represent the victims of personal injury, and specialize in handling serious and catastrophic claims, including traumatic brain injury and concussion. We have decades of experience working closely with our clients to help them obtain fair compensation for their injuries. If you are considering a lawsuit after you, or a family member, suffered a head injury or other serious accident, we offer free consultations to new clients. Contact us online, or call 416-967-9100 to make an appointment with one of our personal injury lawyers.

AUTHOR

concussion

MORE ARTICLES

NMLS, TILA, RESPA, DSCR… What Do They Mean? A Canadian Private Lender’s Guide to Speaking American

One of the biggest surprises Canadian private lenders encounter when expanding into the United States isn't the legal system, it’s

READ ARTICLE →

Judicial vs. Non-Judicial Foreclosure: What Canadian Lenders Need to Know About the U.S. System

For Canadian private lenders looking to expand into the United States, one of the biggest surprises is often the foreclosure

READ ARTICLE →

How Long Does It Take for a Canadian Private Lender to Expand into the United States?

One of the first questions Canadian private lenders ask me is surprisingly simple: "Okay, Jasmine. If we decide we want

READ ARTICLE →

How Canadian Mortgage Brokers Can Legally Fund U.S. Business-Purpose Loans

For decades, Canadian mortgage brokers have built successful businesses helping clients navigate an increasingly competitive lending landscape. But as more

READ ARTICLE →

Canadian Capital vs. American Capital: Can Canadian Private Lenders Raise Money From Both to Fund U.S. Deals?

One of the most common misconceptions I hear from Canadian private lenders looking to expand into the United States is

READ ARTICLE →